LUSPATERCEPT Pharmacologic Class Indexing
- Class set ID
- 0c2dbc58-55c2-4f94-807e-e8a3871945b9
- Version
- 1
- Effective date
- 20230711
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use REBLOZYL safely and effectively. See full prescribing information for REBLOZYL. REBLOZYL ® (luspatercept-aamt) for injection, for subcutaneous use Initial U.S. Approval: 2019 | Celgene Corporation | 20260227 | 20 |